Product Disclosures
Reflecting standard oncology practice, which often requires uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration, this educational activity includes information about many drugs. All faculty participating in continuing education activities are expected to disclose the approved or investigational status (related to the subject matter of this activity—colorectal cancer) of all products and devices under discussion. This information, as of the time of the program launch, is summarized briefly in a table, which can be accessed by selecting the link below. In addition, primary references and full prescribing information should be consulted for complete information. Clinicians have the professional responsibility to ensure that drugs are prescribed and used appropriately, based on their own clinical judgment and accepted standards of care.

To download the product disclosure table for this program, please select this Link.

2008 Meniscus Educational Institute, All Rights Reserved